Russell 2000 Rallies To 16-Month Highs: Best Performing Small-Cap Stocks Popping Over 80% In December

Amidst fanfare for Nasdaq 100, U.S. small-cap stocks rally, with Russell 2000 index reaching levels not seen since Aug. 2022, 80% of stocks trading above 50-day MA, outperforming large caps & Tech-heavy QQQ ETF by 11.4% (MTD)

Amidst the resounding fanfare surrounding the Nasdaq 100’s record-breaking surge, U.S. small-cap stocks have quietly carved out their own moment of glory.

Rally Record: The Russell 2000 index, closely monitored through the iShares Russell 2000 ETF (NYSE:IWM), has experienced a remarkable year-end rally, reaching levels not witnessed since August 2022.

Consistent Climb: This class of stocks has been riding a six-week winning streak, their longest since December 2020, reflecting a sweeping advance rather than isolated successes.

Bullish Breadth: What’s particularly striking is the breadth of this rally, with over 80% of the stocks within the Russell index, accounting for approximately 1,600 companies, trading above their respective 50-day moving averages. This indicates a robust performance across a wide spectrum of small-cap stocks, rather than being limited to a select few.

Outperformance vs. Large Caps: After lagging behind in terms of performance for much of the year, small caps have sharply outperformed their large-cap counterparts in December. The iShares Russell 2000 ETF has surged by an impressive 11.4% during the month. In contrast, the SPDR S&P 500 ETF Trust (NYSE:QQQ), which tracks the Nasdaq 100 index, is up by 5.5%.

Read Also: Small Caps Are ‘Outperforming Everything,’ Analyst Says: This Rally’s Been ‘Years In The Making’

3 Charts Show The Small Caps’ Outstanding Rally In December

1) Small Caps Outperform Large Caps

2) More Than 80% Of Russell 2000’s Stocks Trade Above The 50-Day Moving Average

3) Small Caps Are On The Longest Winning Streak In Three Years

Russell 2000’s Top Gainers In December 2023

Here are the top 10 month-to-date performers in the Russell 2000 as of December 19, 2023:

Name Industry Market Cap Price Chg. % (MTD)
EyePoint Pharmaceuticals, Inc. (NASDAQ:IPSC) Biotechnology $148.99M 81.75%

Read Now: US ETFs Surpass $8 Trillion In Assets: Top 10 Funds Holding Over $100B Each

Photo: Shutterstock

Total
0
Shares
Related Posts
Read More

Declining Interest Rates Should Boost Investment Appeal For Canadian Banks: BofA Analyst

B Of A Securities analyst Ebrahim H. Poonawala revised the rating on several Canadian Banks amid a declining rates scenario. The analyst says the rapid decline in interest rates (5yr yield -120bp since Oct high) lowers the probability of tail risk events posed by a higher for longer scenario. 

BMO